NCT05521633View on ClinicalTrials.gov

Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver

PHASE3CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

June 6, 2019

Primary Completion Date

January 19, 2021

Study Completion Date

May 24, 2022

Conditions
NAFLD
Interventions
DRUG

Metformin and Pioglitazone

Every participant in Group-A took tablet metformin 500 mg daily and every participant in Group-B took tablet pioglitazone 30 mg daily.

Trial Locations (1)

54000

King Edward Medical University/Mayo Hospital, Lahore

All Listed Sponsors
lead

King Edward Medical University

OTHER

NCT05521633 - Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver | Biotech Hunter | Biotech Hunter